BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29798197)

  • 1. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
    Min MK; Zhu MH; Zheng HL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
    Solis RN; Silverman DA; Birkeland AC
    Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of head and neck squamous cell cancer biomarkers.
    Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
    Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head and Neck Cancer in the New Era of Precision Medicine.
    Nör JE; Gutkind JS
    J Dent Res; 2018 Jun; 97(6):601-602. PubMed ID: 29771196
    [No Abstract]   [Full Text] [Related]  

  • 6. Defining the genomic landscape of head and neck cancers through next-generation sequencing.
    Rizzo G; Black M; Mymryk JS; Barrett JW; Nichols AC
    Oral Dis; 2015 Jan; 21(1):e11-24. PubMed ID: 24725020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing the head and neck cancer genome: implications for therapy.
    Sun W; Califano JA
    Ann N Y Acad Sci; 2014 Dec; 1333():33-42. PubMed ID: 25440877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing massively parallel sequencing in personalized head and neck oncology.
    Jessri M; Farah CS
    J Dent Res; 2014 May; 93(5):437-44. PubMed ID: 24557572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
    Giefing M; Wierzbicka M; Szyfter K; Brenner JC; Braakhuis BJ; Brakenhoff RH; Bradford CR; Sorensen JA; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
    Eur J Cancer; 2016 Mar; 55():147-57. PubMed ID: 26851381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving 'omics' technologies for diagnostics of head and neck cancer.
    Nagaraj NS
    Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head and neck cancer: the pursuit of molecular diagnostic markers.
    Hasina R; Lingen MW
    Semin Oncol; 2004 Dec; 31(6):718-25. PubMed ID: 15599849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Models for Predicting Stage in Head and Neck Squamous Cell Carcinoma Using Proteomic and Transcriptomic Data.
    Kaddi CD; Wang MD
    IEEE J Biomed Health Inform; 2017 Jan; 21(1):246-253. PubMed ID: 26462248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Therapy of Head and Neck Squamous Cell Carcinoma.
    Polverini PJ; D'Silva NJ; Lei YL
    J Dent Res; 2018 Jun; 97(6):614-621. PubMed ID: 29649374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and precision surgery for head and neck squamous cell carcinoma.
    Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
    Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
    Lee KD; Lee HS; Jeon CH
    Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
    Lim Y; Sun CX; Tran P; Punyadeera C
    Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in head and neck squamous cell carcinoma: Clinical perspectives.
    Lallemant B; Evrard A; Chambon G; Sabra O; Kacha S; Lallemant JG; Lumbroso S; Brouillet JP
    Head Neck; 2010 Dec; 32(12):1712-9. PubMed ID: 20949446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck.
    Lee CC; Lee MS; Ho HC; Hung SK; Tung YT; Chou P; Su YC
    Clin Chem Lab Med; 2009; 47(10):1277-83. PubMed ID: 19743954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of next generation sequencing in head and neck squamous cell carcinomas: a review.
    Tabatabaeifar S; Kruse TA; Thomassen M; Larsen MJ; Sørensen JA
    Oral Oncol; 2014 Nov; 50(11):1035-40. PubMed ID: 25223596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of electronic nose technology for discriminating between head and neck, bladder, and colon carcinomas.
    van de Goor RM; Leunis N; van Hooren MR; Francisca E; Masclee A; Kremer B; Kross KW
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1053-1060. PubMed ID: 27730323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.